|
171
|
447
|
5ijzA |
Crystal strcuture of glutamate dehydrogenase(gdh) from corynebacterium glutamicum |
|
81
|
284
|
5ia1A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with mln8054 |
|
83
|
291
|
5i9wA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with anp |
|
99
|
360
|
5idpA |
Cdk8-cycc in complex with (3-amino-1h-indazol-5-yl)-[(s)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone |
|
111
|
352
|
5iccA |
Crystal structure of (s)-norcoclaurine 6-o-methyltransferase with s-adenosyl-l-homocysteine |
|
130
|
393
|
5ibhA |
Crystal structure mycobacterium tuberculosis cyp121 in complex with inhibitor fragment 26h |
|
91
|
291
|
5ia2A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with compound 66 |
|
85
|
298
|
5iexA |
Crystal structure of (r,s)-s-{4-[(5-bromo-4-{[(2r,3r)-2-hydroxy-1-methylpropyl]oxy}- pyrimidin-2-yl)amino]phenyl}-s-cyclopropylsulfoximide bound to cdk2 |
|
87
|
292
|
5i9vA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with ags |
|
23
|
76
|
5ibwA |
Complex of mlcc bound to the tandem iq motif of myoc |
|
134
|
394
|
5ibdA |
Crystal structure mycobacterium tuberculosis cyp121 in complex with inhibitor fragment 24a |
|
137
|
410
|
5i94A |
Crystal structure of human glutaminase c in complex with the inhibitor upgl-00019 |
|
130
|
313
|
5i2rA |
Human pde10a in complex with 3-(2-phenylpyrazol-3-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one |
|
50
|
129
|
5ielA |
Structure of lysozyme labeled with fluorescein isothiocyanate (fitc) at 1.15 angstroms resolution |
|
82
|
286
|
5ia0A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with alisertib (mln8237) |
|
102
|
363
|
5idnA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(3-methyl-1h-pyrazolo[3,4-b]pyridin-5-yl)-methanone |
|
82
|
293
|
5i9zA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with danusertib (pha739358) |
|
33
|
114
|
5i8nA |
Solution structure of human calcium-binding s100a9 (c3s) protein |
|
93
|
266
|
5i5zB |
Cdk8-cycc in complex with 8-(1-methyl-2,2-dioxo-2,3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-[1,6]naphthyridine-2-carboxylic acid methylamide |
|
33
|
103
|
5ie9A |
Crystal structure of the bacillus-conserved mazg protein, a nucleotide pyrophosphohydrolase |
|
80
|
295
|
5ia3A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with pd173955 |
|
104
|
365
|
5i5zA |
Cdk8-cycc in complex with 8-(1-methyl-2,2-dioxo-2,3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-[1,6]naphthyridine-2-carboxylic acid methylamide |
|
93
|
268
|
5idpB |
Cdk8-cycc in complex with (3-amino-1h-indazol-5-yl)-[(s)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone |
|
134
|
394
|
5ibeA |
Crystal structure mycobacterium tuberculosis cyp121 in complex with inhibitor fragment 25a |
|
49
|
129
|
5i4wA |
Exploring the onset of lysozyme denaturation by urea |
|
107
|
343
|
5icgA |
Crystal structure of apo (s)-norcoclaurine 6-o-methyltransferase |
|
104
|
362
|
5icpA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]thiadiazol-2-yl)-methanone |
|
116
|
352
|
5iceA |
Crystal structure of (s)-norcoclaurine 6-o-methyltransferase with s-adenosyl-l-homocysteine and norlaudanosoline |
|
90
|
297
|
5i9yA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with dasatinib |
|
91
|
293
|
5i9xA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with bosutinib (ski-606) |
|
100
|
267
|
5icpB |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]thiadiazol-2-yl)-methanone |
|
63
|
242
|
5idjA |
Bifunctional histidine kinase ccka (domains dhp-ca) in complex with adp/mg2+ |
|
90
|
228
|
5iawA |
Novel natural fxr modulator with a unique binding mode |
|
129
|
393
|
5ibiA |
Crystal structure mycobacterium tuberculosis cyp121 in complex with inhibitor fragment 26a |
|
83
|
273
|
5ia4A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with foretinib (xl880) |
|
30
|
91
|
5i4tG |
Immature hexagonal lattice of hiv-1 gag |
|
51
|
129
|
5i4xA |
Exploring onset of lysozyme denaturation by urea - soak period 2 hours |
|
87
|
284
|
5i4nA |
Crystal structure of the e596a v617f mutant jak2 pseudokinase domain bound to mg-atp |
|
79
|
289
|
5i0bA |
Structure of pak4 |
|
102
|
260
|
5i4vA |
Discovery of novel, orally efficacious liver x receptor (lxr) beta agonists |
|
20
|
67
|
5i41B |
Structure of the apo raca dna binding domain |
|
49
|
129
|
5i54A |
Exploring onset of lysozyme denaturation by urea - soak period 4 hours |
|
93
|
304
|
5hznA |
Structure of nvp-aew541 in complex with igf-1r kinase |
|
110
|
287
|
5i3bA |
Crystal structure of tyrosinase from bacillus megaterium with configuration b of hydroquinone inhibitor in the active site |
|
50
|
129
|
5i4yA |
Exploring onset of lysozyme denaturation by urea: soak period 10 hours. |
|
149
|
429
|
5i34A |
Adenylosuccinate synthetase from cryptococcus neoformans complexed with gdp and imp |
|
105
|
287
|
5i3aA |
Crystal structure of tyrosinase from bacillus megaterium with configuration a of hydroquinone inhibitor in the active site |
|
86
|
302
|
5i3rA |
Crystal structure of bmp-2-inducible kinase in complex with an indazole inhibitor |
|
103
|
286
|
5i38A |
Crystal structure of tyrosinase from bacillus megaterium with inhibitor kojic acid in the active site |
|
44
|
120
|
5i14A |
Truncated and mutated t4 lysozyme |
